The ADRU chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADRU chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ADRU stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ADRU Detailed Price Forecast - CNN Money||View ADRU Detailed Summary - Google Finance|
|View ADRU Detailed Summary - Yahoo! Finance||View ADRU Stock Research & Analysis - Zacks.com|
|View ADRU Trends & Analysis - Trade-Ideas||View ADRU Major Holders - Barrons|
|View ADRU Call Transcripts - NASDAQ||View ADRU Breaking News & Analysis - Seeking Alpha|
|View ADRU Annual Report - CompanySpotlight.com||View ADRU OTC Short Report - OTCShortReport.com|
|View ADRU Fundamentals - TradeKing||View ADRU SEC Filings - Bar Chart|
|View Historical Prices for ADRU - The WSJ||View Performance/Total Return for ADRU - Morningstar|
|View the Analyst Estimates for ADRU - MarketWatch||View the Earnings History for ADRU - CNBC|
|View the ADRU Earnings - StockMarketWatch||View ADRU Buy or Sell Recommendations - MacroAxis|
|View the ADRU Bullish Patterns - American Bulls||View ADRU Short Pain Metrics - ShortPainBot.com|
|View ADRU Stock Mentions - StockTwits||View ADRU Stock Mentions - PennyStockTweets|
|View ADRU Stock Mentions - Twitter||View ADRU Investment Forum News - Investor Hub|
|View ADRU Stock Mentions - Yahoo! Message Board||View ADRU Stock Mentions - Seeking Alpha|
|View Insider Transactions for ADRU - SECform4.com||View Insider Transactions for ADRU - Insider Cow|
|View ADRU Major Holdings Summary - CNBC||View Insider Disclosure for ADRU - OTC Markets|
|View Insider Transactions for ADRU - Yahoo! Finance||View Institutional Holdings for ADRU - NASDAQ|
|View ADRU Stock Insight & Charts - FinViz.com||View ADRU Investment Charts - StockCharts.com|
|View ADRU Stock Overview & Charts - BarChart||View ADRU User Generated Charts - Trading View|
A Short Guide to the Novartis-AveXis Deal
Posted on Monday June 04, 2018
On May 15, leading pharmaceutical company Novartis (NVS) acquired AveXis, a US-based clinical-stage gene therapy company. This transaction strengthens Novartis’s position as a leader in gene therapy and neuroscience. The chart below summarizes the deal.
Analysts’ Recommendations for AstraZeneca as of May 15
Posted on Wednesday May 16, 2018
Analysts expect AstraZeneca (AZN) to report EPS (earnings per share) of $0.60 on revenue of $5.3 billion in the first quarter, a 2.3% fall compared to its revenue of $5.4 billion during the first quarter of 2017. AstraZeneca’s stock price has risen nearly 7.1% over the last 12 months and ~4.9% year-to-date.
GlaxoSmithKline’s 1Q18 Earnings: Consumer Healthcare Business
Posted on Monday April 30, 2018
GlaxoSmithKline’s (GSK) Consumer Healthcare business includes various products for oral health, wellness, nutrition, and skin health. The consumer healthcare business reported revenues of ~2.0 billion pounds in 1Q18, a ~3% decrease compared to 1Q17.
Novartis’s 1Q18 Estimates: Expectations for Sandoz
Posted on Wednesday April 18, 2018
Sandoz, the generics arm of Novartis (NVS), includes pharmaceuticals and biotechnological active substances in its portfolio. Sandoz is expected to report growth in operating revenue in 1Q18.